Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Jonathan Silverstein

Affiliations

  • Large Shareholder, Director at Avedro Inc (AVDR), 2019-11-25
  • Director at Restorbio Inc. (TORC), 2019-05-09
  • Director at Glaukos Corp (GKOS), 2018-03-07
  • Director at Scpharmaceuticals Inc. (SCPH), 2017-11-22
  • Director at Rhythm Pharmaceuticals Inc. (RYTM), 2017-10-10
  • Large Shareholder, Director at Roka Bioscience Inc. (ROKA), 2016-09-23
  • Large Shareholder, Director at Audentes Therapeutics Inc. (BOLD), 2016-08-26
  • Director at Intercept Pharmaceuticals Inc (ICPT), 2015-11-28
  • Large Shareholder, Director at Relypsa Inc (RLYP), 2013-11-21
  • Large Shareholder, Director at Nxstage Medical Inc. (NXTM), 2010-05-28
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
TORC $15.00 533,333 Large Shareholder, Director 4,830,387 2018-01-30 Filing
BOLD $15.00 33,334 Large Shareholder, Director 4,801,638 2016-07-25 Filing
ROKA $12.00 3,616 Large Shareholder, Director 30,378 2014-07-22 Filing
ROKA $12.00 379,717 Large Shareholder, Director 3,190,051 2014-07-22 Filing
RLYP $11.00 712,192 Large Shareholder, Director 9,941,551 2013-11-20 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
GKOS $32.06 445 Director 0 2018-03-06 Filing
GKOS $32.06 46,676 Director 0 2018-03-06 Filing
GKOS $30.77 192 Director 445 2018-03-06 Filing
GKOS $30.77 20,114 Director 46,676 2018-03-06 Filing
GKOS $30.01 886 Director 637 2018-03-06 Filing